Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.
AUTOR(ES)
Greenwood, D
RESUMO
The in vitro activity of the new antibacterial agent, flumequine, against Escherichia coli was compared with those of oxolinic acid and nalidixic acid. As judged by turbidimetric criteria, flumequine was considerably more active than nalidixic acid and slightly less active than oxolinic acid against both nalidixic acid-susceptible and -resistant strains. Resistance to all three drugs could be easily induced in vitro. The comparative efficacy of flumequine, oxolinic acid, and nalidixic acid was also tested in an in vitro model of the treatment of bacterial cystitis. In this system, suppression of bacterial growth was obtained with markedly lower concentrations of flumequine and oxolinic acid than of nalidixic acid, but prevention of the emergence of bacterial populations that exhibited increased resistance to these compounds depended on the maintenance of adequate drug levels.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352267Documentos Relacionados
- Comparative In Vitro Studies of Cinoxacin, Nalidixic Acid, and Oxolinic Acid
- Comparative in vitro studies of nalidixic acid, oxolinic acid, and a new analog with thieno (2,3-b) pyridine structure.
- Rosamicin: In Vitro Activity Against Anaerobes and Comparison with Erythromycin
- Induction of Escherichia coli hydroperoxidase I by acetate and other weak acids.
- Chemotactic response of Escherichia coli to chemically synthesized amino acids.
